Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eptacog alfa (activated) 120,000unit inj vials
0211000Z0AAABAB
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 1mg (50,000unit) inj pfs
0211000Z0AAAHAH
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 1mg (50,000unit) inj vials
0211000Z0AAADAD
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 240,000unit inj vials
0211000Z0AAACAC
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 2mg (100,000unit) inj pfs
0211000Z0AAAIAI
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 2mg (100,000unit) inj vials
0211000Z0AAAEAE
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 5mg (250,000unit) inj pfs
0211000Z0AAAJAJ
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 5mg (250,000unit) inj vials
0211000Z0AAAFAF
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 60,000unit inj vials
0211000Z0AAAAAA
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 8mg (400,000unit) inj pfs
0211000Z0AAAKAK
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 8mg (400,000unit) inj vials
0211000Z0AAAGAG
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 1mg (45,000unit) inj vials
0211000Z0AAALAL
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 2mg (90,000unit) inj vials
0211000Z0AAAMAM
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 5mg (225,000unit) inj vials
0211000Z0AAANAN
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.